SEC Form 4 research
| Issuer | Graphite Bio, Inc. |
|---|---|
| Tickers | GRPH, LENZ |
| Reporting owners | 45 |
| Officers and directors | 8 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-10-30 | Chevallard Daniel R. | A | 652,063 | $0 | Not reported |
| 2026-11-02 | 2026-10-29 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M. | S | 107,170 | $3.36 | Not reported |
| 2026-11-02 | 2026-10-29 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M. | S | 451,998 | $3.36 | Not reported |
| 2026-11-02 | 2026-10-29 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M. | S | 2,159,516 | $3.36 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.